Eskildsen-Helmond YE - Search Results

1

Phosphoinositide-generated messengers in cardiac signal transduction.

van Heugten HA, Eskildsen-Helmond YE, de Jonge HW, Bezstarosti K, Lamers JM. van Heugten HA, et al. Mol Cell Biochem. 1996 Apr 12-26;157(1-2):5-14. doi: 10.1007/BF00227875. Mol Cell Biochem. 1996. PMID: 8739223 Review.

2

Endothelin-1-induced phospholipase C-beta and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes.

Lamers JM, Eskildsen-Helmond YE, Resink AM, de Jonge HW, Bezstarosti K, Sharma HS, van Heugten HA. Lamers JM, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S100-3. J Cardiovasc Pharmacol. 1995. PMID: 8587331

3

Regulation and functional significance of phospholipase D in myocardium.

Eskildsen-Helmond YE, Van Heugten HA, Lamers JM. Eskildsen-Helmond YE, et al. Mol Cell Biochem. 1996 Apr 12-26;157(1-2):39-48. doi: 10.1007/BF00227879. Mol Cell Biochem. 1996. PMID: 8739227 Review.

4

Cross-talk between receptor-mediated phospholipase C-beta and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes.

Eskildsen-Helmond YE, Bezstarosti K, Dekkers DH, van Heugten HA, Lamers JM. Eskildsen-Helmond YE, et al. J Mol Cell Cardiol. 1997 Sep;29(9):2545-59. doi: 10.1006/jmcc.1997.0491. J Mol Cell Cardiol. 1997. PMID: 9299377

5

Exploration of the possible roles of phospholipase D and protein kinase C in the mechanism of ischemic preconditioning in the myocardium.

Eskildsen-Helmond YE, Gho BC, Bezstarosti K, Dekkers DH, Soei LK, Van Heugten HA, Verdouw PD, Lamers JM. Eskildsen-Helmond YE, et al. Ann N Y Acad Sci. 1996 Sep 30;793:210-25. doi: 10.1111/j.1749-6632.1996.tb33516.x. Ann N Y Acad Sci. 1996. PMID: 8906167 Review. No abstract available.

6

Does protein kinase C play a pivotal role in the mechanisms of ischemic preconditioning?

Gho BC, Eskildsen-Helmond YE, de Zeeuw S, Lamers JM, Verdouw PD. Gho BC, et al. Among authors: eskildsen helmond ye. Cardiovasc Drugs Ther. 1997 Jan;10(6):775-86. doi: 10.1007/BF00053036. Cardiovasc Drugs Ther. 1997. PMID: 9110122 Free article. Review.

7

Phospholipid source and molecular species composition of 1,2-diacylglycerol in agonist-stimulated rat cardiomyocytes.

Eskildsen-Helmond YE, Hahnel D, Reinhardt U, Dekkers DH, Engelmann B, Lamers JM. Eskildsen-Helmond YE, et al. Cardiovasc Res. 1998 Oct;40(1):182-90. doi: 10.1016/s0008-6363(98)00113-8. Cardiovasc Res. 1998. PMID: 9876331

8

BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.

Thorsen LB, Eskildsen-Helmond Y, Zibrandtsen H, Stasch JP, Simonsen U, Laursen BE. Thorsen LB, et al. Eur J Pharmacol. 2010 Nov 25;647(1-3):147-54. doi: 10.1016/j.ejphar.2010.08.032. Epub 2010 Sep 7. Eur J Pharmacol. 2010. PMID: 20828552

9

The vascular-disrupting agent, combretastatin-A4-phosphate, enhances neurogenic vasoconstriction in rat small arteries.

Su J, Laursen BE, Eskildsen-Helmond Y, Horsman MR, Simonsen U. Su J, et al. Eur J Pharmacol. 2012 Nov 15;695(1-3):104-11. doi: 10.1016/j.ejphar.2012.08.023. Epub 2012 Sep 7. Eur J Pharmacol. 2012. PMID: 22981665

10

Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in pulmonary hypertensive rats.

Østergaard L, Honoré B, Thorsen LB, Baandrup J, Eskildsen-Helmond Y, Laursen BE, Vorum H, Mulvany MJ, Simonsen U. Østergaard L, et al. Proteomics. 2011 Dec;11(23):4492-502. doi: 10.1002/pmic.201100171. Epub 2011 Oct 28. Proteomics. 2011. PMID: 21905223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters